Clinical utility of biomarkers in premature atherosclerosis.
about
Correlation of hippocampal atrophy with hyperhomocysteinemia in hemodialysis patients: An exploratory pilot study.Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophyRenal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China.Plasma T-cadherin negatively associates with coronary lesion severity and acute coronary syndrome.The communal relation of MTHFR, MTR, ACE gene polymorphisms and hyperhomocysteinemia as conceivable risk of coronary artery disease.
P2860
Clinical utility of biomarkers in premature atherosclerosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinical utility of biomarkers in premature atherosclerosis.
@ast
Clinical utility of biomarkers in premature atherosclerosis.
@en
type
label
Clinical utility of biomarkers in premature atherosclerosis.
@ast
Clinical utility of biomarkers in premature atherosclerosis.
@en
prefLabel
Clinical utility of biomarkers in premature atherosclerosis.
@ast
Clinical utility of biomarkers in premature atherosclerosis.
@en
P2093
P1476
Clinical utility of biomarkers in premature atherosclerosis
@en
P2093
A-M Kampoli
C Stefanadis
C Tentolouris
C Toutouzas
D Tousoulis
E Androulakis
G Vogiatzi
N Papageorgiou
P Stougianos
Z Pallatza
P304
P356
10.2174/092986712800493039
P577
2012-01-01T00:00:00Z